IMRT 2018

Canadian H&N IMRT-Review and Consensus

“The case for IMRT in head and neck cancer can be broadly outlined as follows: 1) The data identified in this review, as well as the earlier historical data described in the Introduction, support the contention that IMRT is, at worst, not inferior to two-dimensional CRT with respect to disease control. 2) The data identified in this review, as well as the earlier historical data, support the contention that with IMRT, there are clinically relevant and statistically significant differences in adverse event rates and quality of life compared with two-dimensional CRT.”

O‘Sullivan et al., Clin Oncol, 2012